OIG Issues Special Fraud Alert Regarding Certain Arrangements With Purported Telemedicine Companies

KM
Katten Muchin Rosenman LLP

Contributor

Katten is a firm of first choice for clients seeking sophisticated, high-value legal services globally. Our nationally and internationally recognized practices include corporate, financial markets and funds, insolvency and restructuring, intellectual property, litigation, real estate, structured finance and securitization, transactional tax planning, private credit and private wealth.
On July 20, 2022, the Office of Inspector General issued a Special Fraud Alert cautioning healthcare practitioners about entering into certain types of arrangements with telemedicine companies.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

On July 20, 2022, the Office of Inspector General issued a Special Fraud Alert cautioning healthcare practitioners about entering into certain types of arrangements with telemedicine companies. The alert sets forth 7 characteristics of arrangements which may be suspect and/or present a heightened risk of fraud and abuse. The general information in this Special Fraud Alert and, in particular, the 7 characteristics listed, are worth a review by any practitioner engaging in telehealth efforts with a third-party.

These fraud schemes vary in design and operation, and they have involved a wide range of different individuals and types of entities, including international and domestic telemarketing call centers, staffing companies, Practitioners, marketers, brokers, and others.

https://vmghealth.com/thought-leadership/blog/oig-pu

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More